Showing results (1421-1430 of 2,182) with videos related to
Sort By:
Pageof 219
Journal of Biopharmaceutical Statistics|August 21, 2013
Randomized two-stage Phase II clinical trial designs based on Barnard's exact testGuogen Shan, Changxing Ma, Alan D Hutson, et al.Journal of Biopharmaceutical Statistics|August 21, 2013
Joint modeling of clinical efficacy and safety with an application to diabetes studiesYang Zhao, Wei Shen, Haoda FuJournal of Biopharmaceutical Statistics|August 21, 2013
Decision making from Phase II to Phase III and the probability of success: reassured by "assurance"?Kevin J CarrollJournal of Biopharmaceutical Statistics|April 25, 2013
An approximate approach to sampling size determination for the equivalence hypothesisChing-Ying Hsieh, Jen-Pei LiuJournal of Biopharmaceutical Statistics|April 25, 2013
Large sample tests for simultaneous comparison to multiple controls in terms of binomial proportionsJulia N Soulakova, Linlin LuoJournal of Biopharmaceutical Statistics|April 25, 2013
Approximating the baseline hazard function by taylor series for interval-censored time-to-event dataDing-Geng Chen, Lili Yu, Karl E Peace, et al.Journal of Biopharmaceutical Statistics|June 22, 2013
Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomesJames D Stamey, Fanni Natanegara, John W SeamanJournal of Biopharmaceutical Statistics|June 22, 2013
Crossover versus parallel designs: dose-escalation design comparisons for first-in-human studiesZhiwu Yan, Balakrishna Hosmane, Charles LockeJournal of Biopharmaceutical Statistics|February 27, 2013
A threshold hazard model for estimating serious infection risk following anti-tumor necrosis factor therapy in rheumatoid arthritis patientsBo Fu, Mark Lunt, James Galloway, et al.Journal of Biopharmaceutical Statistics|July 12, 2014
Designing premarket observational comparative studies using existing data as controls: challenges and opportunitiesLilly Q Yue, Nelson Lu, Yunling XuPageof 219